Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type 3 Diabetes and Its Role Implications in Alzheimer’s Disease
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 9, pp. 3165-3165
Open Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Inflammation in obesity, diabetes, and related disorders
Theresa V. Rohm, Daniel T. Meier, Jerrold M. Olefsky, et al.
Immunity (2022) Vol. 55, Iss. 1, pp. 31-55
Open Access | Times Cited: 1107
Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 204
Neuroprotective Effect of SGLT2 Inhibitors
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7213-7213
Open Access | Times Cited: 170
Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer’s disease
Yuanming Li, Jing Zhang, Jiale Wan, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110887-110887
Open Access | Times Cited: 141
Nanotechnology-based drug delivery for central nervous system disorders
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Tuong Kha Vo, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112117-112117
Open Access | Times Cited: 110
Impairment of insulin signaling pathway PI3K/Akt/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: a perspective review
Kanagavalli Ramasubbu, V. Devi Rajeswari
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 6, pp. 1307-1324
Closed Access | Times Cited: 87
Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66
Phytochemicals and Their Usefulness in the Maintenance of Health
Elda Victoria Rodríguez-Negrete, Ángel Morales‐González, Eduardo Madrigal‐Santillán, et al.
Plants (2024) Vol. 13, Iss. 4, pp. 523-523
Open Access | Times Cited: 24
Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
Jéssica Ellen Barbosa de Freitas Lima, Natália Moreira, Elza Tiemi Sakamoto‐Hojo
Mutation Research/Genetic Toxicology and Environmental Mutagenesis (2021) Vol. 874-875, pp. 503437-503437
Closed Access | Times Cited: 102
Advances in developing therapeutic strategies for Alzheimer's disease
Thuy Trang Nguyen, Thi Thuy Dung Nguyen, Thi Kim Oanh Nguyen, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111623-111623
Open Access | Times Cited: 80
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase-4 (DPP4) Inhibitors for New-Onset Dementia: A Propensity Score-Matched Population-Based Study With Competing Risk Analysis
Jonathan V Mui, Jiandong Zhou, Sharen Lee, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 74
Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease
Qianqian Wang, Linyan Duan, Xingfan Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4351-4351
Open Access | Times Cited: 59
Defining the Role of Isoeugenol from Ocimum tenuiflorum against Diabetes Mellitus-Linked Alzheimer’s Disease through Network Pharmacology and Computational Methods
Reshma Mary Martiz, Shashank M. Patil, Mohammed Abdulaziz, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2398-2398
Open Access | Times Cited: 57
Consequences of COVID-19 for the Pancreas
Urszula Abramczyk, Maciej Nowaczyński, Adam Słomczyński, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 864-864
Open Access | Times Cited: 53
Alzheimer’s Disease and Inflammaging
А. М. Косырева, A. V. Sentyabreva, И. С. Цветков, et al.
Brain Sciences (2022) Vol. 12, Iss. 9, pp. 1237-1237
Open Access | Times Cited: 52
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
Haiyang Du, Xiaoyu Meng, Yao Yu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 49
The Role of Obesity and Diabetes in Dementia
Ashley Selman, Scott Burns, Arubala P. Reddy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9267-9267
Open Access | Times Cited: 48
Contributions of physical inactivity and sedentary behavior to metabolic and endocrine diseases
Nathan R. Kerr, Frank W. Booth
Trends in Endocrinology and Metabolism (2022) Vol. 33, Iss. 12, pp. 817-827
Closed Access | Times Cited: 44
Diabetes Mellitus is Associated With Higher Serum Neurofilament Light Chain Levels in the General US Population
Stefano Ciardullo, Emanuele Muraca, Eleonora Bianconi, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 2, pp. 361-367
Closed Access | Times Cited: 43
Pathogenesis of Dementia
Janusz Błaszczyk
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 543-543
Open Access | Times Cited: 42
Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer’s Disease: A Narrative Review
Silvia Di Giacomo, Ester Percaccio, Marco Gullì, et al.
Nutrients (2022) Vol. 14, Iss. 18, pp. 3709-3709
Open Access | Times Cited: 41
Diet and lifestyle impact the development and progression of Alzheimer’s dementia
Sarah Arora, José A. Santiago, Melissa Bernstein, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 36
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
Maria Chiara Pelle, Isabella Zaffina, Federica Giofrè, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11301-11301
Open Access | Times Cited: 30
Anti-Cholinesterase and Anti-α-Amylase Activities and Neuroprotective Effects of Carvacrol and p-Cymene and Their Effects on Hydrogen Peroxide Induced Stress in SH-SY5Y Cells
Lucia Caputo, Giuseppe Amato, Laura De Martino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6073-6073
Open Access | Times Cited: 29
High-Intensity Interval Training Ameliorates Molecular Changes in the Hippocampus of Male Rats with the Diabetic Brain: the Role of Adiponectin
Kayvan Khoramipour, Mohammad Abbas Bejeshk, Mohammad Amin Rajizadeh, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 6, pp. 3486-3495
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top